vs

Side-by-side financial comparison of CAPRICOR THERAPEUTICS, INC. (CAPR) and CEMTREX INC (CETX). Click either name above to swap in a different company.

CEMTREX INC is the larger business by last-quarter revenue ($16.1M vs $11.1M, roughly 1.4× CAPRICOR THERAPEUTICS, INC.). CAPRICOR THERAPEUTICS, INC. runs the higher net margin — -63.9% vs -127.4%, a 63.5% gap on every dollar of revenue. On growth, CEMTREX INC posted the faster year-over-year revenue change (17.4% vs -7.9%). CEMTREX INC produced more free cash flow last quarter ($-1.1M vs $-15.3M). Over the past eight quarters, CAPRICOR THERAPEUTICS, INC.'s revenue compounded faster (93.0% CAGR vs -3.0%).

Capricor Therapeutics is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative biological therapies including cell and gene therapies for rare diseases, cardiovascular disorders and muscular conditions. It primarily operates in the U.S. market, addressing unmet medical needs for patient groups with limited treatment options.

Cemtrex Inc is a diversified industrial technology firm developing IoT-enabled industrial automation solutions, environmental monitoring systems, and digital workplace tools. Its core clients are from manufacturing, industrial and commercial sectors, mainly in North America and European markets.

CAPR vs CETX — Head-to-Head

Bigger by revenue
CETX
CETX
1.4× larger
CETX
$16.1M
$11.1M
CAPR
Growing faster (revenue YoY)
CETX
CETX
+25.3% gap
CETX
17.4%
-7.9%
CAPR
Higher net margin
CAPR
CAPR
63.5% more per $
CAPR
-63.9%
-127.4%
CETX
More free cash flow
CETX
CETX
$14.2M more FCF
CETX
$-1.1M
$-15.3M
CAPR
Faster 2-yr revenue CAGR
CAPR
CAPR
Annualised
CAPR
93.0%
-3.0%
CETX

Income Statement — Q4 FY2024 vs Q1 FY2026

Metric
CAPR
CAPR
CETX
CETX
Revenue
$11.1M
$16.1M
Net Profit
$-7.1M
$-20.6M
Gross Margin
34.8%
Operating Margin
-69.1%
-17.4%
Net Margin
-63.9%
-127.4%
Revenue YoY
-7.9%
17.4%
Net Profit YoY
-833.8%
28.5%
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPR
CAPR
CETX
CETX
Q4 25
$16.1M
Q3 25
$18.5M
Q2 25
$17.0M
Q1 25
$27.3M
Q4 24
$11.1M
$13.7M
Q3 24
$2.3M
$18.1M
Q2 24
$4.0M
$14.7M
Q1 24
$4.9M
$17.2M
Net Profit
CAPR
CAPR
CETX
CETX
Q4 25
$-20.6M
Q3 25
$-3.4M
Q2 25
$-4.5M
Q1 25
$8.4M
Q4 24
$-7.1M
$-28.8M
Q3 24
$-12.6M
$4.4M
Q2 24
$-11.0M
$-9.0M
Q1 24
$-9.8M
$-1.5M
Gross Margin
CAPR
CAPR
CETX
CETX
Q4 25
34.8%
Q3 25
38.0%
Q2 25
43.4%
Q1 25
44.6%
Q4 24
41.5%
Q3 24
41.8%
Q2 24
40.0%
Q1 24
40.4%
Operating Margin
CAPR
CAPR
CETX
CETX
Q4 25
-17.4%
Q3 25
-6.4%
Q2 25
-3.8%
Q1 25
16.9%
Q4 24
-69.1%
-16.6%
Q3 24
-575.2%
-1.8%
Q2 24
-291.9%
-21.6%
Q1 24
-209.2%
-6.0%
Net Margin
CAPR
CAPR
CETX
CETX
Q4 25
-127.4%
Q3 25
-18.1%
Q2 25
-26.8%
Q1 25
30.8%
Q4 24
-63.9%
-209.3%
Q3 24
-555.2%
24.1%
Q2 24
-277.0%
-61.2%
Q1 24
-199.6%
-8.6%
EPS (diluted)
CAPR
CAPR
CETX
CETX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-0.11
Q3 24
$-0.38
Q2 24
$-0.35
Q1 24
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPR
CAPR
CETX
CETX
Cash + ST InvestmentsLiquidity on hand
$151.5M
$20.5M
Total DebtLower is stronger
$12.8M
Stockholders' EquityBook value
$145.5M
$29.1M
Total Assets
$170.5M
$60.3M
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPR
CAPR
CETX
CETX
Q4 25
$20.5M
Q3 25
$5.0M
Q2 25
$7.0M
Q1 25
$4.5M
Q4 24
$151.5M
$4.2M
Q3 24
$85.0M
$3.9M
Q2 24
$29.5M
$6.5M
Q1 24
$39.9M
$2.9M
Total Debt
CAPR
CAPR
CETX
CETX
Q4 25
$12.8M
Q3 25
$13.5M
Q2 25
$18.3M
Q1 25
$18.9M
Q4 24
$18.7M
Q3 24
$18.0M
Q2 24
Q1 24
$21.6M
Stockholders' Equity
CAPR
CAPR
CETX
CETX
Q4 25
$29.1M
Q3 25
$8.7M
Q2 25
$3.6M
Q1 25
$6.4M
Q4 24
$145.5M
$-1.6M
Q3 24
$68.3M
$4.7M
Q2 24
$11.5M
$48.0K
Q1 24
$18.4M
$4.7M
Total Assets
CAPR
CAPR
CETX
CETX
Q4 25
$60.3M
Q3 25
$47.8M
Q2 25
$47.0M
Q1 25
$46.2M
Q4 24
$170.5M
$46.7M
Q3 24
$93.0M
$44.1M
Q2 24
$38.3M
$43.8M
Q1 24
$49.4M
$47.2M
Debt / Equity
CAPR
CAPR
CETX
CETX
Q4 25
0.44×
Q3 25
1.55×
Q2 25
5.07×
Q1 25
2.94×
Q4 24
Q3 24
3.82×
Q2 24
Q1 24
4.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPR
CAPR
CETX
CETX
Operating Cash FlowLast quarter
$-14.8M
$-891.9K
Free Cash FlowOCF − Capex
$-15.3M
$-1.1M
FCF MarginFCF / Revenue
-137.3%
-6.7%
Capex IntensityCapex / Revenue
4.4%
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.2M
$-721.5K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPR
CAPR
CETX
CETX
Q4 25
$-891.9K
Q3 25
$-3.3M
Q2 25
$1.8M
Q1 25
$2.8M
Q4 24
$-14.8M
$-1.2M
Q3 24
$-11.6M
$-1.9M
Q2 24
$-12.3M
$675.8K
Q1 24
$-1.3M
$386.8K
Free Cash Flow
CAPR
CAPR
CETX
CETX
Q4 25
$-1.1M
Q3 25
$-3.7M
Q2 25
$1.7M
Q1 25
$2.4M
Q4 24
$-15.3M
$-2.1M
Q3 24
$-11.7M
$-2.7M
Q2 24
$-12.3M
$601.7K
Q1 24
$-1.9M
$322.2K
FCF Margin
CAPR
CAPR
CETX
CETX
Q4 25
-6.7%
Q3 25
-20.2%
Q2 25
10.2%
Q1 25
8.7%
Q4 24
-137.3%
-15.5%
Q3 24
-515.2%
-15.1%
Q2 24
-310.9%
4.1%
Q1 24
-38.3%
1.9%
Capex Intensity
CAPR
CAPR
CETX
CETX
Q4 25
1.1%
Q3 25
2.7%
Q2 25
0.4%
Q1 25
1.6%
Q4 24
4.4%
6.7%
Q3 24
0.4%
4.8%
Q2 24
1.5%
0.5%
Q1 24
12.4%
0.4%
Cash Conversion
CAPR
CAPR
CETX
CETX
Q4 25
Q3 25
Q2 25
Q1 25
0.33×
Q4 24
Q3 24
-0.43×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAPR
CAPR

Segment breakdown not available.

CETX
CETX

Industrial Services$10.6M66%
Security$5.5M34%

Related Comparisons